EZH2 and neoplasm: CircGSK3B directly binds to EZH2 and inhibits the binding of EZH2 and H3K27me3 to the RORA promoter, leading to elevated RORA expression and inhibiting tumor progression by suppressing the growth, invasion, and metastasis of gastric cancer cells (Ma X. et al., 2021).